Details for Patent: 7,655,637

✉ Email this page to a colleague

Summary for Patent: 7,655,637

Title:	N-pyrazole A.sub.2A receptor agonists
Abstract:	2-adenosine N-pyrazole compounds having the following formula: ##STR00001## wherein R.sup.1.dbd.CH.sub.2OH; R.sup.2 is hydrogen; R.sup.3 is selected from the group consisting of CO.sub.2R.sup.20; --CONR.sup.7R.sup.8 ,and aryl wherein the aryl substituent is optionally substituted with one substituent selected from the group consisting of halo, C .sub.1-3alkyl and OR.sup.20;R.sup.4 is hydrogen; R.sup.7 is selected from hydrogen, and C.sub.1-3alkyl; R.sup.8 is hydrogen; and R.sup.20 is selected from hydrogen and methyl as well as methods for using the compositions as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart are disclosed.
Inventor(s):	Zablocki; Jeff A. (Mountain View, CA), Elzein; Elfatih O. (Fremont, CA), Palle; Venkata (Pune, IN), Belardinelli; Luiz (Palo Alto, CA)
Assignee:	Gilead Palo Alto, Inc. (Foster City, CA)
Application Number:	11/588,834
Patent Claim Types: see list of patent claims	Compound; Use; Composition; Formulation;

Drugs Protected by US Patent 7,655,637

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 7,655,637

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1189916	⤷ Sign Up	C300477	Netherlands	⤷ Sign Up
European Patent Office	1189916	⤷ Sign Up	CA 2011 00005	Denmark	⤷ Sign Up
European Patent Office	1189916	⤷ Sign Up	91785	Luxembourg	⤷ Sign Up
European Patent Office	1189916	⤷ Sign Up	SPC004/2011	Ireland	⤷ Sign Up
European Patent Office	1189916	⤷ Sign Up	1190003-2.L	Sweden	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.